首页|低频重复经颅磁刺激联合舍曲林治疗强迫症患者的效果

低频重复经颅磁刺激联合舍曲林治疗强迫症患者的效果

扫码查看
目的:观察低频重复经颅磁刺激联合舍曲林治疗强迫症患者的效果.方法:选取 2021 年 1 月至 2024 年 1 月该院收治的90 例强迫症患者进行前瞻性研究,按照随机数字表法将其分为对照组和观察组各 45 例.对照组予以舍曲林治疗,观察组在对照组基础上联合低频重复经颅磁刺激治疗,比较两组临床疗效,治疗前后抑郁[汉密尔顿抑郁量表(HAMD)]评分、焦虑[汉密尔顿焦虑量表(HAMA)]评分、神经递质[5-羟色胺(5-HT)、多巴胺(DA)、兴奋性氨基酸(EAA)]水平,以及不良反应发生率.结果:观察组治疗总有效率为 93.33%(42/45),高于对照组的 68.89%(31/45),差异有统计学意义(P<0.05);治疗后,两组HAMD、HAMA评分均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);两组 5-HT、DA及EAA水平均高于治疗前,且观察组高于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:低频重复经颅磁刺激联合舍曲林治疗强迫症患者可提高临床疗效,缓解焦虑、抑郁情绪,提高神经递质水平,效果优于单纯舍曲林治疗.
Effects of low frequency repetitive transcranial stimulation combined with Sertraline in treatment of patients with obsessive-compulsive disorder
Objective:To observe effects of low frequency repetitive transcranial stimulation combined with Sertraline in treatment of patients with obsessive-compulsive disorder.Methods:A prospective study was conducted on 90 patients with obsessive-compulsive disorder admitted to the hospital from January 2021 to January 2024.According to the random number table method,they were divided into control group and observation group,45 cases in each group.The control group was treated with Sertraline,while the observation group was treated with low frequency repetitive transcranial stimulation on the basis of that of the control group.The clinical efficacy,the scores of depression[Hamilton depression scale(HAMD)]and anxiety[Hamilton anxiety scale(HAMA)]before and after the treatment,the levels of neurotransmitters[5-hydroxytryptamine(5-HT),dopamine(DA),excitatory amino acid(EAA)],and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the observation group was 93.33%(42/45),which was higher than 68.89%(31/45)of the control group,and the difference was statistically significant(P<0.05).After the treatment,the scores of HAMD and HAMA in the two groups were lower than those before the treatment,those in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).The levels of 5-HT,DA and EAA in the two groups were higher than those before the treatment,those in the observation group were higher than those in the control group and,the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Low frequency repetitive transcranial stimulation combined with Sertraline in the treatment of the patients with obsessive-compulsive disorder can improve the clinical efficacy,relieve the anxiety and depression,and improve the levels of neurotransmitters.Moreover,it is superior to simple Sertraline treatment.

Obsessive-compulsive disorderSertralineLow frequency repetitive transcranial stimulationNeurotransmitterAnxietyDepressionAdverse reaction

崔哲、王晓琳

展开 >

淄博市第五人民医院,心理科,山东 淄博 255000

淄博市第五人民医院,临床营养室,山东 淄博 255000

强迫症 舍曲林 低频重复经颅磁刺激 神经递质 焦虑 抑郁 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(19)
  • 14